These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 26252723)
21. The implications of methylphenidate use by healthy medical students and doctors in South Africa. Beyer C; Staunton C; Moodley K BMC Med Ethics; 2014 Mar; 15():20. PubMed ID: 24592964 [TBL] [Abstract][Full Text] [Related]
22. What should we do about student use of cognitive enhancers? An analysis of current evidence. Ragan CI; Bard I; Singh I; Neuropharmacology; 2013 Jan; 64():588-95. PubMed ID: 22732441 [TBL] [Abstract][Full Text] [Related]
23. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signaling. Liechti M Swiss Med Wkly; 2015; 145():w14043. PubMed ID: 25588018 [TBL] [Abstract][Full Text] [Related]
27. [Options, limits and ethics of pharmacological neuroenhancement]. Normann C; Boldt J; Maio G; Berger M Nervenarzt; 2010 Jan; 81(1):66-74. PubMed ID: 19851745 [TBL] [Abstract][Full Text] [Related]
28. The use and misuse of prescription stimulants as "cognitive enhancers" by students at one academic health sciences center. Bossaer JB; Gray JA; Miller SE; Enck G; Gaddipati VC; Enck RE Acad Med; 2013 Jul; 88(7):967-71. PubMed ID: 23702522 [TBL] [Abstract][Full Text] [Related]
29. The use of methylphenidate among students: the future of enhancement? Outram SM J Med Ethics; 2010 Apr; 36(4):198-202. PubMed ID: 20338928 [TBL] [Abstract][Full Text] [Related]
30. Caffeine use by children: the quest for enhancement. Bramstedt KA Subst Use Misuse; 2007; 42(8):1237-51. PubMed ID: 17674233 [TBL] [Abstract][Full Text] [Related]
31. Neuroenhancement and mood enhancement – Physiological and pharmacodynamical background. Weiergräber M; Ehninger D; Broich K Med Monatsschr Pharm; 2017 Apr; 40(4):154-64. PubMed ID: 29952165 [TBL] [Abstract][Full Text] [Related]
33. Pharmacological Neuroenhancement in the Field of Economics-Poll Results from an Online Survey. Dietz P; Soyka M; Franke AG Front Psychol; 2016; 7():520. PubMed ID: 27148128 [TBL] [Abstract][Full Text] [Related]
34. The Changing Drug Culture: Use and Misuse of Cognition-Enhancing Drugs. Albertson TE; Chenoweth JA; Colby DK; Sutter ME FP Essent; 2016 Feb; 441():25-9. PubMed ID: 26881770 [TBL] [Abstract][Full Text] [Related]
35. [Neuroenhancement: doping for the brain]. Bruhn C Dtsch Med Wochenschr; 2009 Oct; 134(40):p35. PubMed ID: 19790040 [No Abstract] [Full Text] [Related]
37. Recommendations for the ethical use of pharmacologic fatigue countermeasures in the U.S. military. Russo MB Aviat Space Environ Med; 2007 May; 78(5 Suppl):B119-27; discussion B128-37. PubMed ID: 17547313 [TBL] [Abstract][Full Text] [Related]
38. Self-management of psychiatric symptoms using over-the-counter (OTC) psychopharmacology: the S-DTM therapeutic model--Self-diagnosis, self-treatment, self-monitoring. Charlton BG Med Hypotheses; 2005; 65(5):823-8. PubMed ID: 16111835 [TBL] [Abstract][Full Text] [Related]
39. The Use of Caffeinated Substances by Surgeons for Cognitive Enhancement. Franke AG; Bagusat C; McFarlane C; Tassone-Steiger T; Kneist W; Lieb K Ann Surg; 2015 Jun; 261(6):1091-5. PubMed ID: 25072440 [TBL] [Abstract][Full Text] [Related]
40. Stimulant Use by Medical Students. Trojanowska M J S C Med Assoc; 2015; 111(1):32. PubMed ID: 27124986 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]